US Patent No. 8,900,627

Compositions for the in vivo delivery of RNAi agents
Dec 04, 2014

Mirna Therpeutics and Bioo Scientific have been awarded US Patent No. 8,900,627, "Compositions for the in vivo delivery of RNAi agents."

Lance Ford, David Brown, and Andrea Bader are named as the inventors.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.